Europe's medicines regulator said Wednesday it will make a recommendation on the safety of Johnson & Johnson's coronavirus jab next week after U.S. health authorities recommended pausing vaccinations over blood clot fears. 

The "EMA is expediting this evaluation and currently expects to issue a recommendation next week," it said in a statement, after announcing last week a probe had been launched. 

Following the U.S., more countries like Romania, Denmark and Iceland are putting a hold on the use of Johnson & Johnson's jab pending probe.